SYNCONA LIMITED
RELEASED IN ERROR
17 December 2018
The 'Change of Registered Office' announcement released on 17 December 2018 at 11.47am under RNS No 7019K was released in error and should be disregarded.
[ENDS]
Enquiries
Syncona Ltd
Annabel Clay
Tel: +44 (0)20 3981 7928
Copies of this and other corporate information can be found on the company website at: www.synconaltd.com
About Syncona:
Syncona is a leading FTSE250 healthcare company focused on founding, building and funding global leaders in life science. Our vision is to deliver transformational treatments to patients in truly innovative areas of healthcare while generating superior returns for shareholders.
We seek to partner with the best, brightest and most ambitious minds in science to build globally competitive businesses.
We take a long-term view, underpinned by a deep pool of capital, and are established leaders in gene and cell therapy. We focus on delivering dramatic efficacy for patients in areas of high unmet need.
